Get started
Author

Yakup Ergün

Comparison of HER2-zero and HER2-low in terms of clinicopathological factors and survival in early-stage breast cancer: A systematic review and meta-analysis
2023 · Yakup Ergun, Gokhan Ucar, et al. · Cancer Treatment Reviews · 72
Immunogenicity and Safety of the Coronavac Vaccine in Patients with Cancer Receiving Active Systemic Therapy
2021 · Cengiz Karacin, Tulay Eren, et al. · Future Oncology · 39
PDF
Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients
2020 · Tulay Eren, Cengiz Karacin, et al. · Medicine · 25
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
2023 · Cengiz Karacin, Berna Oksuzoglu, et al. · BMC Cancer · 24
PDF
Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
2020 · Gokhan Ucar, Yakup Ergun, et al. · Medicine · 24
The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer
2020 · Gokhan Ucar, Yakup Ergun, et al. · Asia-Pacific Journal of Clinical Oncology · 24
The Role of Artificial Intelligence (ChatGPT-4o) in Supporting Tumor Board Decisions
2025 · Berkan Karabuğa, Cengiz Karaçin, et al. · Journal of Clinical Medicine · 23
PDF
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases
2024 · Seda Kahraman, Serdar Karakaya, et al. · Scientific Reports · 20
Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study.
2019 · Yakup Ergun, Nuriye Yildirim Ozdemir, et al. · PubMed · 16
Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
2020 · Yakup Ergun, Oznur Bal, et al. · Journal of Research in Medical Sciences · 14
The Effect of HER2-Low Status on Pathological Complete Response and Survival in Triple-Negative Breast Cancer: A Systemic Review and Meta-Analysis
2023 · Yakup Ergun, Baran Akagunduz, et al. · Clinical Breast Cancer · 11
Role of hepatosteatosis in HBsAg seroconversion in HBeAg‐negative chronic hepatitis B patients
2021 · Ferhat Bacaksız, Hale Gökcan, et al. · International Journal of Clinical Practice · 11
PDF
Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospective analysis.
2018 · Yakup Ergun, Nuriye Yildirim Ozdemir, et al. · PubMed · 11
Efficacy of adjuvant CDK4/6 inhibitors in hormone receptor-positive breast cancer: a systematic review and meta-analysis
2023 · Yakup Ergun, Mutlu Dogan, et al. · Expert Opinion on Pharmacotherapy · 10
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group
2021 · Mustafa Gürbüz, Erman Akkuş, et al. · Journal of Gastrointestinal Cancer · 10
Gastric Cancer Patients with Bone Marrow Metastasis: A Single-Center Experience and Review of the Literature
2017 · Yakup Ergun, Dogan Uncu, et al. · Eurasian Journal of Medicine and Oncology · 10
Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study
2025 · Maral Martin Mildanoglu, Yasin Kutlu, et al. · Scientific Reports · 9
PDF
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2025 · Yasin Sezgin, Oğur Karhan, et al. · Scientific Reports · 9
PDF
KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer
2019 · Yakup Ergun, Yusuf Acikgoz, et al. · Expert Review of Molecular Diagnostics · 9
Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy
2024 · Yusuf Ilhan, Gokhan Ucar, et al. · Expert Opinion on Pharmacotherapy · 8
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study
2023 · Ahmet Bilici, Sinan Koca, et al. · Journal of Cancer Research and Clinical Oncology · 8
PDF
The effect of chemotherapy on olfactory function and mucociliary clearance
2020 · Fakih Cihat Eravcı, Gökhan Uçar, et al. · Supportive Care in Cancer · 8
HER3 in breast cancer: molecular insights, clinical implications, and therapeutic horizons
2025 · Yakup Ergun · Expert Opinion on Therapeutic Targets · 7
Neoadjuvant or Perioperative Immunotherapy in Resectable Non-Small Cell Lung Cancer: Pooled Analysis of Subgroups in Randomized Controlled Trial
2024 · Yakup Ergun · Eurasian Journal of Medicine and Oncology · 7
The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)
2022 · Mutlu Hizal, Burak Bilgin, et al. · Journal of Cancer Research and Clinical Oncology · 7
PDF
Works count: 118
Citation count: 574
H-index: 11
I10-index: 16
Year
Topic
Type